Heartflow, Inc. (HTFL) · Insider trading

What Heartflow's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months

$1.05M

1 insider, 1 trade

Sold, 12 months

$140.00M

5 insiders, 18% under a plan

Net, 12 months

−$138.95M

bought less sold

Latest filing

2026-10-14

filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

Bought Sold Largest month: $61.09M

Who traded, two years

Insider	Bought	Sold	Trades	Last trade	Holds after
Bain Capital Life Sciences Investors, LLC10% owner	–	$115.00M	5	2026-04-30	–
Farquhar John C.m.Director, Chief Executive Officer	–	$12.87M	15	2026-10-12	283,014
Rogers CampbellChief Medical Officer	–	$6.71M	7	2026-09-18	79,956
Verghese VikramChief Financial Officer	–	$4.98M	8	2026-09-18	155,183
Lightcap Jeffrey CDirector	$1.05M	–	1	2025-12-16	40,000
Cullivan Julie ADirector	–	$446,610	2	2026-03-05	27,291

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

Date	Insider	Trade	Shares	Price	Value	Holds after	Filing
2026-10-12	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	38,900	49.57	$1.93M	283,014	Form 4
2026-09-18	Rogers CampbellChief Medical Officer	Saleplan	19,682	50.15	$987,052	79,956	Form 4
2026-09-18	Verghese VikramChief Financial Officer	Saleplan	16,766	50.75	$850,874	155,183	Form 4
2026-09-17	Verghese VikramChief Financial Officer	Saleplan	7,579	50.11	$379,784	171,949	Form 4
2026-09-15	Verghese VikramChief Financial Officer	Saleplan	668	50.01	$33,407	179,528	Form 4
2026-09-14	Verghese VikramChief Financial Officer	Saleplan	4,593	50.24	$230,752	180,196	Form 4
2026-09-11	Verghese VikramChief Financial Officer	Saleplan	29,714	50.06	$1.49M	184,789	Form 4
2026-09-11	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	3,890	50.00	$194,500	321,914	Form 4
2026-09-10	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	35,010	46.42	$1.63M	325,804	Form 4
2026-09-08	Verghese VikramChief Financial Officer	Saleplan	6,640	50.03	$332,199	214,503	Form 4
2026-09-03	Verghese VikramChief Financial Officer	Saleplan	27,540	49.69	$1.37M	221,143	Form 4
2026-09-02	Verghese VikramChief Financial Officer	Saleplan	5,876	50.60	$297,326	248,683	Form 4
2026-08-21	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	27,230	50.00	$1.36M	360,814	Form 4
2026-08-18	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	32,676	45.00	$1.47M	388,044	Form 4
2026-08-17	Rogers CampbellChief Medical Officer	Saleplan	9,219	41.23	$380,099	86,459	Form 4
2026-08-14	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	15,560	39.06	$607,774	420,720	Form 4
2026-08-10	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	22,562	28.31	$638,730	436,280	Form 4
2026-07-15	Rogers CampbellChief Medical Officer	Saleplan	9,219	25.72	$237,113	88,731	Form 4
2026-07-10	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	22,562	27.75	$626,096	435,373	Form 4
2026-06-24	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	38,900	35.00	$1.36M	457,935	Form 4
2026-06-10	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	22,562	28.50	$643,017	496,835	Form 4
2026-05-18	Rogers CampbellChief Medical Officer	Saleplan	9,219	28.34	$261,266	78,731	Form 4
2026-05-11	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	22,562	29.12	$657,005	519,397	Form 4
2026-04-30	Bain Capital Life Sciences Investors, LLC10% ownerwith Bain Capital Life Sciences Fund III, L.P., Bcls Fund III Investments GP, LLC, Bain Capital Life Sciences III General Partner, LLC, Bcls Fund III Investments, LP	Saleindirect	892,533	29.18	$26.04M	8,504,382	Form 4
2026-04-30	Bain Capital Life Sciences Investors, LLC10% ownerwith Bain Capital Life Sciences Fund III, L.P., Bcls Fund III Investments GP, LLC, Bain Capital Life Sciences III General Partner, LLC, Bcls Fund III Investments, LP	Saleindirect	56,224	30.05	$1.69M	8,448,158	Form 4
2026-04-29	Bain Capital Life Sciences Investors, LLC10% ownerwith Bain Capital Life Sciences Fund III, L.P., Bcls Fund III Investments GP, LLC, Bain Capital Life Sciences III General Partner, LLC, Bcls Fund III Investments, LP	Saleindirect	797,133	29.37	$23.41M	9,396,915	Form 4
2026-04-28	Bain Capital Life Sciences Investors, LLC10% ownerwith Bain Capital Life Sciences Fund III, L.P., Bcls Fund III Investments GP, LLC, Bain Capital Life Sciences III General Partner, LLC, Bcls Fund III Investments, LP	Saleindirect	254,110	30.51	$7.75M	10,194,048	Form 4
2026-04-10	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	22,562	26.72	$602,857	549,163	Form 4
2026-04-01	Rogers CampbellChief Medical Officer	Saleplan	64,533	24.64	$1.59M	81,002	Form 4
2026-03-19	Rogers CampbellChief Medical Officer	Saleplan	64,533	25.69	$1.66M	78,518	Form 4
2026-03-18	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	9,725	25.00	$243,125	571,725	Form 4
2026-03-10	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	12,837	22.66	$290,886	581,450	Form 4
2026-03-05	Cullivan Julie ADirector	Saleplan	9,122	25.00	$228,050	27,291	Form 4
2026-02-12	Rogers CampbellChief Medical Officer	Saleplan	65,153	24.49	$1.60M	76,034	Form 4
2026-02-10	Farquhar John C.m.Director, Chief Executive Officer	Saleplan	22,562	27.46	$619,553	591,656	Form 4
2026-02-05	Cullivan Julie ADirector	Saleplan	8,000	27.32	$218,560	36,413	Form 4
2026-02-04	Bain Capital Life Sciences Investors, LLC10% ownerwith Bain Capital Life Sciences Fund III, L.P., Bcls Fund III Investments GP, LLC, Bain Capital Life Sciences III General Partner, LLC, Bcls Fund III Investments, LP	Saleindirect	2,000,000	28.05	$56.10M	10,448,158	Form 4
2025-12-16	Lightcap Jeffrey CDirector	Buy	40,000	26.34	$1.05M	40,000	Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

28 × option exercise24 × shares withheld for tax15 × conversion11 × grant or award2 × other

Show them

Date	Insider	What	Shares	Price	Holds after	Filing
2026-09-18	Rogers CampbellChief Medical Officer	Option exercise M	+12,329	8.33	98,788	Form 4
2026-09-18	Rogers CampbellChief Medical Officer	Option exercise M	+850	2.22	99,638	Form 4
2026-08-17	Rogers CampbellChief Medical Officer	Option exercise M	+9,219	19.00	95,678	Form 4
2026-08-07	Farquhar John C.m.Director, Chief Executive Officer	Shares withheld for tax F	−1,904	28.82	458,842	Form 4
2026-08-07	Rogers CampbellChief Medical Officer	Shares withheld for tax F	−637	28.82	86,459	Form 4
2026-08-07	Verghese VikramChief Financial Officer	Shares withheld for tax F	−473	28.82	254,559	Form 4
2026-08-07	Jones Marie L.Chief Accounting Officer	Shares withheld for tax F	−82	28.82	32,176	Form 4
2026-08-06	Farquhar John C.m.Director, Chief Executive Officer	Shares withheld for tax F	−5,847	27.19	460,746	Form 4
2026-08-06	Rogers CampbellChief Medical Officer	Shares withheld for tax F	−1,635	27.19	87,096	Form 4
2026-08-06	Verghese VikramChief Financial Officer	Shares withheld for tax F	−1,537	27.19	255,032	Form 4
2026-08-06	Jones Marie L.Chief Accounting Officer	Shares withheld for tax F	−486	27.19	32,258	Form 4
2026-07-30	Farquhar John C.m.Director, Chief Executive Officer	Option exercise M	+2,789	8.33	438,162	Form 4
2026-07-30	Farquhar John C.m.Director, Chief Executive Officer	Option exercise M	+18,694	2.22	456,856	Form 4
2026-07-30	Farquhar John C.m.Director, Chief Executive Officer	Option exercise M	+9,737	9.58	466,593	Form 4
2026-07-27	Verghese VikramChief Financial Officer	Option exercise M	+22,522	2.22	255,898	Form 4
2026-07-24	Lightcap Jeffrey CDirector	Option exercise M	+47,420	19.00	293,681	Form 4
2026-07-22	Barabe Timothy CDirector	Option exercise M	+3,710	19.00	188,231	Form 4
2026-07-21	Verghese VikramChief Financial Officer	Option exercise M	+22,522	2.22	233,376	Form 4
2026-07-17	Barabe Timothy CDirector	Option exercise M	+5,000	19.00	184,521	Form 4
2026-07-15	Rogers CampbellChief Medical Officer	Option exercise M	+9,219	19.00	97,950	Form 4
2026-07-08	Weldon William CDirector	Option exercise M	+17,123	8.33	209,685	Form 4
2026-07-08	Weldon William CDirector	Option exercise M	+17,123	8.33	226,808	Form 4
2026-07-08	Weldon William CDirector	Option exercise M	+17,123	8.33	243,931	Form 4
2026-06-15	Rogers CampbellChief Medical Officer	Option exercise M	+10,000	2.22	88,731	Form 4
2026-05-18	Rogers CampbellChief Medical Officer	Option exercise M	+9,219	19.00	87,950	Form 4
2026-05-07	Farquhar John C.m.Director, Chief Executive Officer	Shares withheld for tax F	−1,904	29.98	541,959	Form 4
2026-05-07	Verghese VikramChief Financial Officer	Shares withheld for tax F	−473	29.98	210,854	Form 4
2026-05-07	Rogers CampbellChief Medical Officer	Shares withheld for tax F	−637	29.98	78,731	Form 4
2026-05-07	Jones Marie L.Chief Accounting Officer	Shares withheld for tax F	−82	29.98	31,083	Form 4
2026-05-06	Farquhar John C.m.Director, Chief Executive Officer	Shares withheld for tax F	−5,300	30.29	543,863	Form 4
2026-05-06	Verghese VikramChief Financial Officer	Shares withheld for tax F	−1,536	30.29	211,327	Form 4
2026-05-06	Rogers CampbellChief Medical Officer	Shares withheld for tax F	−1,634	30.29	79,368	Form 4
2026-05-06	Jones Marie L.Chief Accounting Officer	Shares withheld for tax F	−485	30.29	31,165	Form 4
2026-04-01	Rogers CampbellChief Medical Officer	Option exercise M	+291	8.33	78,809	Form 4
2026-04-01	Rogers CampbellChief Medical Officer	Option exercise M	+19,111	2.22	97,920	Form 4
2026-04-01	Rogers CampbellChief Medical Officer	Option exercise M	+40,766	2.22	138,686	Form 4
2026-04-01	Rogers CampbellChief Medical Officer	Option exercise M	+6,849	2.22	145,535	Form 4
2026-03-24	Lightcap Jeffrey CDirector	Other J	+206,261	–	246,261	Form 4
2026-03-24	HealthCor Partners Management LPDirector	Other J	−4,615,542	–	0	Form 4
2026-03-19	Rogers CampbellChief Medical Officer	Option exercise M	+19,402	2.22	95,436	Form 4
2026-03-19	Rogers CampbellChief Medical Officer	Option exercise M	+47,615	2.22	143,051	Form 4
2026-03-11	Barabe Timothy CDirector	Option exercise M	+8,667	2.22	179,521	Form 4
2026-03-06	Verghese VikramChief Financial Officer	Grant or award A	+671	16.15	213,534	Form 4
2026-03-06	Jones Marie L.Chief Accounting Officer	Grant or award A	+1,661	16.15	33,311	Form 4
2026-03-06	Farquhar John C.m.Director, Chief Executive Officer	Grant or award A	+2,631	16.15	594,287	Form 4
2026-02-17	Barabe Timothy CDirector	Option exercise M	+2,497	8.33	170,854	Form 4
2026-02-12	Rogers CampbellChief Medical Officer	Option exercise M	+19,401	2.22	93,572	Form 4
2026-02-12	Rogers CampbellChief Medical Officer	Option exercise M	+39,709	8.33	133,281	Form 4
2026-02-12	Rogers CampbellChief Medical Officer	Option exercise M	+7,906	2.22	141,187	Form 4
2026-02-06	Verghese VikramChief Financial Officer	Shares withheld for tax F	−542	27.74	144,370	Form 4
2026-02-06	Verghese VikramChief Financial Officer	Grant or award A	+68,493	–	212,863	Form 4
2026-02-06	Rogers CampbellChief Medical Officer	Shares withheld for tax F	−515	27.74	20,098	Form 4
2026-02-06	Rogers CampbellChief Medical Officer	Grant or award A	+54,073	–	74,171	Form 4
2026-02-06	Farquhar John C.m.Director, Chief Executive Officer	Shares withheld for tax F	−1,541	27.74	430,368	Form 4
2026-02-06	Farquhar John C.m.Director, Chief Executive Officer	Grant or award A	+183,850	–	614,218	Form 4
2026-02-06	Jones Marie L.Chief Accounting Officer, VP	Shares withheld for tax F	−94	27.74	10,021	Form 4
2026-02-06	Jones Marie L.Chief Accounting Officer, VP	Grant or award A	+21,629	–	31,650	Form 4
2025-11-07	Jones Marie L.Chief Accounting Officer, VP	Shares withheld for tax F	−81	32.56	10,115	Form 4
2025-11-07	Verghese VikramChief Financial Officer	Shares withheld for tax F	−471	32.56	144,912	Form 4
2025-11-07	Farquhar John C.m.Director, Chief Executive Officer	Shares withheld for tax F	−1,339	32.56	431,909	Form 4
2025-11-07	Rogers CampbellChief Medical Officer	Shares withheld for tax F	−439	32.56	20,613	Form 4
2025-08-11	HealthCor Partners Fund LP10% owner	Conversion C	+1,248,939	–	1,248,939	Form 4
2025-08-11	HealthCor Partners Fund LP10% owner	Conversion C	+833,075	–	833,075	Form 4
2025-08-11	HealthCor Partners Fund LP10% owner	Conversion C	+4,615,542	–	4,615,542	Form 4
2025-08-11	Bain Capital Life Sciences Investors, LLC10% owner	Conversion C	+12,014,234	–	12,014,234	Form 4
2025-08-11	Bain Capital Life Sciences Investors, LLC10% owner	Conversion C	+433,924	15.20	12,448,158	Form 4
2025-08-11	Lightcap Jeffrey CDirector	Conversion C	+833,075	–	833,075	Form 4
2025-08-11	Lightcap Jeffrey CDirector	Conversion C	+1,248,939	–	1,248,939	Form 4
2025-08-11	Lightcap Jeffrey CDirector	Conversion C	+4,615,542	–	4,615,542	Form 4
2025-08-11	Tansey Casey MDirector	Conversion C	+3,072,759	–	3,072,759	Form 4
2025-08-11	Tansey Casey MDirector	Conversion C	+98,303	–	98,303	Form 4
2025-08-11	Tansey Casey MDirector	Conversion C	+16,447	–	16,447	Form 4
2025-08-11	Barabe Timothy CDirector	Conversion C	+131,578	–	168,357	Form 4
2025-08-11	Jones Marie L.Chief Accounting Officer, VP	Conversion C	+6,578	–	10,196	Form 4
2025-08-11	Verghese VikramChief Financial Officer	Conversion C	+9,516	–	145,383	Form 4
2025-08-11	Weldon William CDirector	Conversion C	+136,286	–	192,562	Form 4
2025-08-07	Jones Marie L.Chief Accounting Officer, VP	Grant or award A	+3,618	–	3,618	Form 4
2025-08-07	Rogers CampbellChief Medical Officer	Grant or award A	+21,052	–	21,052	Form 4
2025-08-07	Verghese VikramChief Financial Officer	Grant or award A	+21,052	–	135,867	Form 4
2025-08-07	Farquhar John C.m.Director, Chief Executive Officer	Grant or award A	+59,868	–	433,248	Form 4

How to read it

Buy, sale: Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan: A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after: The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value: Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Heartflow's scores and multiples ›